Picture of ADBiotech Co logo

179530 ADBiotech Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for ADBiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7,345-2,6642,696-5,432-8,987
Depreciation
Amortisation
Non-Cash Items6,7561,425-7,0684575,272
Unusual Items
Other Non-Cash Items
Changes in Working Capital-612-1,574-4,9464,156-1,402
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,019-2,162-8,592315-4,092
Capital Expenditures-5,289-3,561-727-290-193
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items706-963-1,4722,6971,435
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4,583-4,524-2,1992,4071,241
Financing Cash Flow Items-2.12-12.8-3970-8.83
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6,7425,43310,794-885484
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,128-1,243-16.21,836-2,376
0